Expressions of IGF-1R and IGFBP3 in Advanced Non-small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Kim, Y. H. [1 ]
Sumiyoshi, S. [1 ]
Hashimoto, S. [1 ]
Masago, K. [1 ]
Togashi, Y. [1 ]
Sakamori, Y. [1 ]
Okuda, C. [1 ]
Mio, T. [1 ]
Mishima, M. [1 ]
机构：
[1] Kyoto Univ Hosp, Kyoto 606, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72455-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S636 / S636
页数：1
相关论文
共 50 条
  • [1] IGF-1R and EGFR expression and IGF-1R mutational status in non-small cell lung cancer (NSCLC)
    Forde, Lydia
    Gately, Kathy
    Gray, Stephen
    Cuffe, Sinead
    Easty, David
    O'Byrne, Ken
    CANCER RESEARCH, 2010, 70
  • [2] TARGETING THE IGF-1R SIGNALLING PATHWAY IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Forde, Lydia
    Gray, Steven G.
    Gately, Kathy
    O'Byrne, Kenneth J.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S775 - S776
  • [3] Targeting the IGF-1R signalling pathway in non-small cell lung cancer (NSCLC)
    Forde, L.
    Gately, K.
    Gray, S. G.
    O'Byrne, K. J.
    LUNG CANCER, 2011, 71 : S4 - S4
  • [4] Role of IGF-1/IGFBP3 in non-small cell lung cancer sensitivity to therapy.
    Ibanez de Caceres, Inmaculada
    Holgado, Esther
    Pernia, Olga
    De Castro, Javier
    Hitt, Ricardo
    Conde, Esther
    Lopez-Rios, Fernando
    Cortes Semperes, Maria
    Perona, Rosario
    Belda-Iniesta, Cristobal
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] IGF1R expression & mutational status in non-small cell lung cancer (NSCLC)
    Forde, Lydia
    Gately, Kathy
    Gray, Stephen
    Cuffe, Sinead
    O'Byrne, Ken
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S616 - S616
  • [6] Inhibiting IGF-1R attenuates cell proliferation and VEGF production in IGF-1R over-expressing EGFR mutant non-small cell lung cancer cells
    Yeo, Chang Dong
    Kim, Young Ae
    Lee, Hwa Young
    Kim, Jin Woo
    Lee, Sang Haak
    Kim, Seung Joon
    Kwon, Soon Seog
    Kim, Yong Hyun
    Kim, Seok Chan
    EXPERIMENTAL LUNG RESEARCH, 2017, 43 (01) : 29 - 37
  • [7] Chemotherapy for advanced non-small cell lung cancer (NSCLC)
    Manegold, C
    LUNG CANCER, 2002, 38 : S47 - S50
  • [8] CLINICAL SIGNIFICANCE OF IGF-1R AND MMP-7 EXPRESSION IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Yamamoto, Taketsugu
    Oshima, Takashi
    Yoshihara, Kazue
    Nishii, Teppei
    Arai, Hiromasa
    Inui, Kenji
    Adachi, Hiroyuki
    Rino, Yasushi
    Masuda, Munetaka
    Imada, Toshio
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S968 - S969
  • [9] IGF-1R Inhibition in Small Cell Lung Cancer: Role of Brigatinib
    Lakshmanan, I.
    Chaudhary, S.
    Perumal, N. K.
    Batra, S.
    Ganti, A. K.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S221 - S221
  • [10] COMBINED INHIBITION OF IGF-1R ENHANCES THE EFFECTS OF GEFITINIB IN A HUMAN NON-SMALL CELL LUNG CANCER RESISTANT CELL LINE
    Qi, H.
    RESPIROLOGY, 2011, 16 : 183 - 183
12345